-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the CPM New Drug Research and Development Monitoring Database (cpm.
Figure 1 Monthly trend of the number of over-comment approvals
Data source: CPM database
According to CPM database statistics, up to now, the number of over-rated generic drugs has reached 466 (in terms of generic name + dosage form), of which 46 have been over-rated for the first time since 2021.
Among the 46 varieties reviewed for the first time this year, there are 2 large varieties that rank within the top 50 in terms of drug consumption in sample hospitals, 4 rank within 50 to 100, and 6 rank within 100 to 500, accounting for a total of About 1/4 (Figure 2).
Figure 2 The ranking of the amount of drugs used in the sample hospitals for the first time this year
Data source: CPM database
Table 1 Varieties reviewed for the first time in 2021
(Sales top 100 sample hospitals in 2020)
Nowadays, the national centralized drug procurement work has entered normalization.
Figure 3 Competition situation of over-rated enterprises
Data source: CPM database
Judging from the past national drug collection bidding varieties, it is possible for the over-evaluated companies to collect 2 companies to be included in the collection.
Table 2 Many companies have been evaluated and have not yet been included in the national collection of varieties
(Sales top 100 sample hospitals in 2020)